Work

Psychosis Risk and Development: What Do We Know From Population-Based Studies?

Year: 2019

Type: review

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2019.12.014

Authors: Eva Mennigen, Carrie E. Bearden

Institutions: University of California, Los Angeles, University Hospital Carl Gustav Carus, Technische Universität Dresden

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Wellcome Trust, Medical Research Council, National Institute of Mental Health

Awards: Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial, The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi-generation, longitudinal resource, Genetic Risk for Developmental Expression of Neuropsychiatric Intermediate Traits, The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi- generation, longitudinal resource focusing on life course health and well- being., "1/9-Predictors and Mechanisms of Conversion to Psychosis, The Avon Longitudinal Study of Parents and Children: An international resource for population genomics and lifecourse epidemiology. Core Programme Support 2011-2015 and Core programme support 2014-2019, Center for Neurocognition and Emotion in Schizophrenia, Neurodevelopment and Psychosis in the 22q11.2 Copy Number Variants

OpenAlex ID: W2996381406

FWCI: 0.536

Cites: 137

Cited by: 42

Related to: 10